Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium

Authors: Day, Jonathan R. ^{1, 2}, Larson, Melissa C. ³, Durani, Urshila ², Koff, Jean L. ⁴, Wang, Yucai ², Habermann, Thomas M. ², Lossos, Izidore S. ⁵, Nastoupil, Loretta J. ⁶, Strouse, Christopher ¹, Chihara, Dai ⁶, Martin, Peter ⁷, Leonard, John P. ⁷, Cohen, Jonathon B. ⁴, Kahl, Brad S. ⁸, Ruan, Jia ⁷, Burack, W. Richard ⁹, Friedberg, Jonathan W. ⁹, Cerhan, James R. ³, Flowers, Christopher R. ⁶, Link, Brian K. ¹, Maurer, Matthew J. ³, Casulo, Carla ^{9, ∗}

Source: In Blood Advances 11 March 2025 9(5):1013-1023

Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience

Authors: Hwang, Steven R. ¹, Godby, Richard C. ¹, Negaard, Brianna J. ², Mwangi, Raphael ², Nedved, Adrienne N. ³, Barreto, Jason N. ³, Micallef, Ivana N. ¹, Ansell, Stephen M. ¹, Porrata, Luis ¹, Durani, Urshila ¹, Thanarajasingam, Gita ¹, Habermann, Thomas M. ¹, Maurer, Matthew J. ², Johnston, Patrick B. ¹, Khurana, Arushi ^{1, ∗}

Source: In Blood Advances 25 February 2025 9(4):924-932

End points and outcomes in follicular lymphoma: what should we measure, how, and why?

Authors: Di, Mengyang ^{1, 2, 3}, Maurer, Matthew J. ^{4, 5}, Flowers, Christopher R. ^{6, ∗}

Source: In Blood February 2025

Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature

Authors: Bommier, Côme ^{1, 2, 3}, Link, Brian K. ⁴, Gysbers, Brianna J. ¹, Maurer, Matthew J. ^{1, 5}, Larson, Melissa C. ¹, Khurana, Arushi ⁵, Wang, Yucai ⁵, Thompson, Carrie A. ⁵, Chihara, Dai ⁶, Alderuccio, Juan P. ⁷, Koff, Jean L. ⁸, Epperla, Narendranath ⁹, Conconi, Annarita ¹⁰, Lossos, Izidore S. ⁷, Nowakowski, Grzegorz S. ⁵, Feldman, Andrew L. ¹¹, Habermann, Thomas M. ⁵, King, Rebecca L. ¹¹, Cerhan, James R. ^{1, ∗}

Source: In Blood Advances 10 December 2024 8(23):5939-5948

Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL

Authors: Khurana, Arushi, Mwangi, Raphael, Nastoupil, Loretta J., Reagan, Patrick M., Farooq, Umar, Romancik, Jason T., McDonnell, Timothy J., Riska, Shaun M., Lossos, lzidore S., Kahl, Brad S., Martin, Peter, Witzig, Thomas E., Cerhan, James R., Flowers, Christopher R., Nowakowski, Grzegorz S., Maurer, Matthew J.

Source: In Blood Advances 27 August 2024 8(16):4414-4422

Defining primary refractory large B-cell lymphoma

Authors: Bock, Allison M., Mwangi, Raphael, Wang, Yucai, Khurana, Arushi, Maurer, Matthew J., Ayers, Amy, Kahl, Brad S., Martin, Peter, Cohen, Jonathon B., Casulo, Carla, Lossos, Izidore S., Farooq, Umar, Ayyappan, Sabarish, Reicks, Tanner, Habermann, Thomas M., Witzig, Thomas E., Flowers, Christopher R., Cerhan, James R., Nastoupil, Loretta J., Nowakowski, Grzegorz S.

Source: In Blood Advances 9 July 2024 8(13):3402-3415

Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment

Authors: Arcaini, Luca, Bommier, Côme, Alderuccio, Juan Pablo, Merli, Michele, Fabbri, Nicole, Nizzoli, Maria Elena, Maurer, Matthew J., Tarantino, Vittoria, Ferrero, Simone, Rattotti, Sara, Talami, Annalisa, Murru, Roberta, Khurana, Arushi, Mwangi, Raphael, Deodato, Marina, Cencini, Emanuele, Re, Francesca, Visco, Carlo, Feldman, Andrew L., Link, Brian K., Delamain, Marcia Torresan, Spina, Michele, Annibali, Ombretta, Pulsoni, Alessandro, Ferreri, Andrés J.M., Stelitano, Caterina Cecilia, Pennese, Elsa, Habermann, Thomas M., Marcheselli, Luigi, Han, Sunwoo, Reis, Isildinha M., Paulli, Marco, Lossos, Izidore S., Cerhan, James R., Luminari, Stefano

Source: In eClinicalMedicine June 2024 72

Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP

Authors: Bantilan, Kurt S., Smith, Alexandra N., Maurer, Matthew J., Teruya-Feldstein, Julie, Matasar, Matthew J., Moskowitz, Alison J., Straus, David J., Noy, Ariela, Palomba, M. Lia, Horwitz, Steven M., Hamlin, Paul A., Portlock, Carol S., Cerhan, James R., Habermann, Thomas M., Salles, Gilles A., Nowakowski, Grzegorz S., Moskowitz, Craig H., Zelenetz, Andrew D.

Source: In Blood Advances 14 May 2024 8(9):2172-2181

Harnessing multi-source data for individualized care in Hodgkin Lymphoma

Authors: Parsons, Susan K., Rodday, Angie Mae, Upshaw, Jenica N., Scharman, Carlton D., Cui, Zhu, Cao, Yenong, Tiger, Yun Kyoung Ryu, Maurer, Matthew J., Evens, Andrew M.

Source: In Blood Reviews May 2024 65

Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments

Authors: Krull, Jordan E., Wenzl, Kerstin, Hopper, Melissa A., Manske, Michelle K., Sarangi, Vivekananda, Maurer, Matthew J., Larson, Melissa C., Mondello, Patrizia, Yang, ZhiZhang, Novak, Joseph P., Serres, Makayla, Whitaker, Kaitlyn R., Villasboas Bisneto, Jose C., Habermann, Thomas M., Witzig, Thomas E., Link, Brian K., Rimsza, Lisa M., King, Rebecca L., Ansell, Stephen M., Cerhan, James R., Novak, Anne J.

Source: In Cell Reports Medicine 19 March 2024 5(3)

Early complete response as a validated surrogate marker in extranodal marginal zone lymphoma systemic therapy

Authors: Bommier, Côme, Zucca, Emanuele, Chevret, Sylvie, Conconi, Annarita, Nowakowski, Grzegorz, Maurer, Matthew J., Cerhan, James R., Thieblemont, Catherine, Lambert, Jérôme

Source: In Blood 1 February 2024 143(5):422-428

Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma

Authors: Nastoupil, Loretta J. ^{1, ⁎}, Andersen, Clark R. ¹, Ayers, Amy ¹, Wang, Yucai ², Habermann, Thomas M. ², Chihara, Dai ¹, Kahl, Brad S. ³, Link, Brian K. ⁴, Koff, Jean L. ⁵, Cohen, Jonathon B. ⁵, Martin, Peter ⁶, Lossos, Izidore S. ⁷, Stanchina, Michele ⁷, Haddadi, Sara ⁸, Casulo, Carla ⁹, Ayyappan, Sabarish ⁴, Lin, Ruitao ¹³, Li, Ziyi ¹³, Larson, Melissa A. ¹⁴, Maurer, Matthew J. ¹⁴, Huynh, Lynn ¹², Gao, Chi ¹², Ramasubramanian, Ramya ¹², Duh, Mei Sheng ¹², Mutebi, Alex ¹⁰, Wang, Tongsheng ¹⁰, Jun, Monika ¹⁰, Wang, Anthony ¹¹, Kamalakar, Rajesh ¹¹, Kalsekar, Anupama ¹⁰, Cerhan, James R. ¹⁵, Flowers, Christopher R. ¹

Source: In Clinical Lymphoma, Myeloma and Leukemia April 2025 25(4):e183-e199

Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma

Authors: Villa, Diego, Jiang, Aixiang, Visco, Carlo, Crosbie, Nicola, McCulloch, Rory, Buege, Michael J., Kumar, Anita, Bond, David A., Paludo, Jonas, Maurer, Matthew J., Thanarajasingam, Gita, Lewis, Katharine L., Cheah, Chan Y., Baech, Joachim, El-Galaly, Tarec C., Kugathasan, Laveniya, Scott, David W., Gerrie, Alina S., Lewis, David

Source: In Blood Advances 22 August 2023 7(16):4576-4585

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Authors: Epperla, Narendranath ^∗, Switchenko, Jeffrey, Bachanova, Veronika, Gerson, James N., Barta, Stefan K., Gordon, Max J., Danilov, Alexey V., Grover, Natalie S., Mathews, Stephanie, Burkart, Madelyn, Karmali, Reem, Sawalha, Yazeed, Hill, Brian T., Ghosh, Nilanjan, Park, Steven I., Bond, David A., Hamadani, Mehdi, Fenske, Timothy S., Martin, Peter, Malecek, Mary-Kate, Kahl, Brad S., Flowers, Christopher R., Link, Brian K., Kaplan, Lawrence D., Inwards, David J., Feldman, Andrew L., Hsi, Eric D., Maddocks, Kami, Blum, Kristie A., Bartlett, Nancy L., Cerhan, James R., Leonard, John P., Habermann, Thomas M., Maurer, Matthew J., Cohen, Jonathon B.

Source: In Blood Advances 13 June 2023 7(11):2287-2296

Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis

Authors: Desai, Sanjal H., Mwangi, Raphael, Ng, Wern Lynn, King, Rebecca L., Maurer, Matthew J., Cerhan, James R., Feldman, Andrew L., Farooq, Umar, Mou, Eric, Habermann, Thomas M., Thompson, Carrie A., Wang, Yucai, Witzig, Thomas E., Nowakowski, Grzegorz S.

Source: In Blood Advances 27 December 2022 6(24):6180-6186

Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study

Authors: Tun, Aung M., Khurana, Arushi, Mwangi, Raphael, Link, Brian K., Wang, Yucai, Feldman, Andrew L., Thompson, Carrie A., Novak, Anne J., Villasboas, Jose C., Thanarajasingam, Gita, Farooq, Umar, Syrbu, Sergei, Nowakowski, Grzegorz S., Witzig, Thomas E., Ansell, Stephen M., Rimsza, Lisa M., Cerhan, James R., Habermann, Thomas M. ^*, Maurer, Matthew J. ^{*, *}

Source: In Blood Advances 13 September 2022 6(17):5210-5221

CNS prophylaxis for diffuse large B-cell lymphoma

Authors: Eyre, Toby A ^*, Savage, Kerry J, Cheah, Chan Y, El-Galaly, Tarec C, Lewis, Katharine L, McKay, Pamela, Wilson, Matthew R, Evens, Andrew M, Bobillo, Sabela, Villa, Diego, Maurer, Matthew J, Cwynarski, Kate, Ferreri, Andrés J M

Source: In The Lancet Oncology September 2022 23(9):e416-e426

Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis

Authors: Luan, Danny, Fatola, Tolulope, Toure, Ahmed, Flowers, Christopher R., Link, Brian, Friedberg, Jonathan W., Cohen, Jonathon B., Kahl, Brad, Lossos, Izidore S., Nastoupil, Loretta, Maurer, Matthew J., Cerhan, James R., Martin, Peter ^*

Source: In Blood Advances 9 August 2022 6(15):4413-4423

Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study

Authors: Casulo, Carla ^*, Larson, Melissa C, Lunde, Julianne J, Habermann, Thomas M, Lossos, Izidore S, Wang, Yucai, Nastoupil, Loretta J, Strouse, Christopher, Chihara, Dai, Martin, Peter, Cohen, Jonathon B, Kahl, Brad S, Burack, W Richard, Koff, Jean L, Mun, Yong, Masaquel, Anthony, Wu, Mei, Wei, Michael C, Shewade, Ashwini, Li, Jia, Cerhan, James, Flowers, Christopher R, Link, Brian K, Maurer, Matthew J

Source: In The Lancet Haematology April 2022 9(4):e289-e300

Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes

Authors: Castellino, Alessia ^*, Wang, Yucai ^{*, *}, Larson, Melissa C., Maurer, Matthew J., Link, Brian K., Farooq, Umar, Feldman, Andrew L., Syrbu, Sergei I., Habermann, Thomas M., Paludo, Jonas, Inwards, David J., Witzig, Thomas E., Ansell, Stephen M., Allmer, Cristine, Slager, Susan L., Cohen, Jonathon B., Martin, Peter, Cerhan, James R., Nowakowski, Grzegorz S. ^*

Source: In Blood Advances 22 February 2022 6(4):1350-1360